Thomasvtran, Od, Pa | |
350 Robert Smalls Pkwy, Beaufort, SC 29906-4284 | |
(843) 522-9755 | |
(843) 521-3085 |
Full Name | Thomasvtran, Od, Pa |
---|---|
Type | Facility |
Speciality | Optometrist |
Location | 350 Robert Smalls Pkwy, Beaufort, South Carolina |
Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144340019 | NPI | - | NPPES |
1518030485 | Other | SC | DR. EMILY B. TRAN'S NPI # |
D12387 | Medicaid | SC | |
DB3713 | Other | SC | RAILROAD MC GROUP# |
$$$$$$$$$ | Other | SC | EMILY TRAN'S SSN |
1871664904 | Other | SC | DR THOMAS V TRAN'S NPI # |
DA9742 | Medicaid | SC | |
P00100411 | Other | SC | RAILROAD MC PIN # |
D12396 | Medicaid | SC | |
$$$$$$$$$ | Other | SC | THOMAS TRAN'S SSN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | SC1238, SC1239 (South Carolina) | Primary |
Provider Name | Thomas Van Tran |
---|---|
Provider Type | Practitioner - Optometry |
Provider Identifiers | NPI Number: 1871664904 PECOS PAC ID: 4789865627 Enrollment ID: I20110224000596 |
News Archive
Emmaus Medical, Inc., a pharmaceutical company developing a new treatment for sickle cell disease, and subsidiary of Emmaus Life Sciences, Inc., announced today that its investigational L-glutamine treatment for sickle cell disease has received a positive opinion recommending orphan medicinal product designation by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP). The designation allows Emmaus ten years of marketing exclusivity in EU member countries after the product obtains marketing authorization, as well as streamlined regulatory review processes and registration and other fee reductions.
Researchers from the translational research program of the National Cancer Institute and the Radiation Therapy Oncology Therapy Group have developed new guidelines to help fast track the clinical development of targeted cancer drugs in combination with radiation therapy.
In a study published online today in the American Journal of Obstetrics & Gynecology, researchers from the Sequenom Center for Molecular Medicine confirmed that DNA sequencing of maternal blood plasma could accurately detect trisomy 21.
Fewer than 50 percent of adolescent medical checkups include preventive health counseling, despite the demonstrated effectiveness of doctor-delivered advice in promoting healthy behavior as well as reducing risky behavior in teens.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Thomasvtran, Od, Pa 20 Hayek St, Beaufort, SC 29907-2068 Ph: (843) 522-0613 | Thomasvtran, Od, Pa 350 Robert Smalls Pkwy, Beaufort, SC 29906-4284 Ph: (843) 522-9755 |
News Archive
Emmaus Medical, Inc., a pharmaceutical company developing a new treatment for sickle cell disease, and subsidiary of Emmaus Life Sciences, Inc., announced today that its investigational L-glutamine treatment for sickle cell disease has received a positive opinion recommending orphan medicinal product designation by the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP). The designation allows Emmaus ten years of marketing exclusivity in EU member countries after the product obtains marketing authorization, as well as streamlined regulatory review processes and registration and other fee reductions.
Researchers from the translational research program of the National Cancer Institute and the Radiation Therapy Oncology Therapy Group have developed new guidelines to help fast track the clinical development of targeted cancer drugs in combination with radiation therapy.
In a study published online today in the American Journal of Obstetrics & Gynecology, researchers from the Sequenom Center for Molecular Medicine confirmed that DNA sequencing of maternal blood plasma could accurately detect trisomy 21.
Fewer than 50 percent of adolescent medical checkups include preventive health counseling, despite the demonstrated effectiveness of doctor-delivered advice in promoting healthy behavior as well as reducing risky behavior in teens.
› Verified 8 days ago
Niko Olavi Vahamaki, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 Pinckney Blvd, Beaufort, SC 29902 Phone: 843-228-5478 | |
Dr. Richard Wan, OD, MS Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1 Pinckney Blvd, Beaufort, SC 29902 Phone: 843-228-5200 | |
Eye Care One Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11 Robert Smalls Pkwy, Suite H, Beaufort, SC 29906 Phone: 843-524-8302 | |
Shell Point Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: 204 Midtown Dr, Beaufort, SC 29906 Phone: 843-521-4037 Fax: 843-521-0138 | |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 204 Midtown Dr, Beaufort, SC 29906 Phone: 843-521-4037 | |
Dr. Raymond Ellsworth Jimison Ii, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11 Robert Smalls Pkwy, Beaufort, SC 29906 Phone: 843-524-8302 Fax: 843-379-5974 |